CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: VISCOSUPPLEMENTATION MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Single Injection Viscosupplementation
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Three Injection Viscosupplementation
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Five Injection Viscosupplementation
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: VISCOSUPPLEMENTATION MARKET, BY APPLICATION
5.1 Overview
5.1.1 Market size and forecast
5.2 Knee Osteoarthritis
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Knee Osteoarthritis Viscosupplementation Market by Gender
5.2.4.1 Male Market size and forecast, by region
5.2.4.2 Female Market size and forecast, by region
5.3 Hip Osteoarthritis
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Hand Osteoarthritis
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Others
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
CHAPTER 6: VISCOSUPPLEMENTATION MARKET, BY DISTRIBUTION CHANNEL
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital Pharmacies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Retail Pharmacies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Online Pharmacies
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: VISCOSUPPLEMENTATION MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Application
7.2.3.1 North America Knee Osteoarthritis Viscosupplementation Market by Gender
7.2.4 North America Market size and forecast, by Distribution channel
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Application
7.2.5.1.3 Market size and forecast, by Distribution channel
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Application
7.2.5.2.3 Market size and forecast, by Distribution channel
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Application
7.2.5.3.3 Market size and forecast, by Distribution channel
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Application
7.3.3.1 Europe Knee Osteoarthritis Viscosupplementation Market by Gender
7.3.4 Europe Market size and forecast, by Distribution channel
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Application
7.3.5.1.3 Market size and forecast, by Distribution channel
7.3.5.2 France
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Application
7.3.5.2.3 Market size and forecast, by Distribution channel
7.3.5.3 UK
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Application
7.3.5.3.3 Market size and forecast, by Distribution channel
7.3.5.4 Italy
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Application
7.3.5.4.3 Market size and forecast, by Distribution channel
7.3.5.5 Spain
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Application
7.3.5.5.3 Market size and forecast, by Distribution channel
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Application
7.3.5.6.3 Market size and forecast, by Distribution channel
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Application
7.4.3.1 Asia-Pacific Knee Osteoarthritis Viscosupplementation Market by Gender
7.4.4 Asia-Pacific Market size and forecast, by Distribution channel
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Application
7.4.5.1.3 Market size and forecast, by Distribution channel
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Application
7.4.5.2.3 Market size and forecast, by Distribution channel
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Application
7.4.5.3.3 Market size and forecast, by Distribution channel
7.4.5.4 Australia
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Application
7.4.5.4.3 Market size and forecast, by Distribution channel
7.4.5.5 South Korea
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Application
7.4.5.5.3 Market size and forecast, by Distribution channel
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Application
7.4.5.6.3 Market size and forecast, by Distribution channel
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Application
7.5.3.1 LAMEA Knee Osteoarthritis Viscosupplementation Market by Gender
7.5.4 LAMEA Market size and forecast, by Distribution channel
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Application
7.5.5.1.3 Market size and forecast, by Distribution channel
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Application
7.5.5.2.3 Market size and forecast, by Distribution channel
7.5.5.3 South Africa
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Application
7.5.5.3.3 Market size and forecast, by Distribution channel
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Application
7.5.5.4.3 Market size and forecast, by Distribution channel
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Seikagaku Corporation
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 Anika Therapeutics, Inc.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 aptissen
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Avanos Medical, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Bioventus
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Chugai Pharmaceutical Corp.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Fidia Farmaceutici S.P.A
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 LG Life Sciences Ltd.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Sanofi
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Miravo Healthcare
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
| ※参考情報 関節内補充治療（Viscosupplementation）は、主に変形性関節症や関節炎の治療に用いられる医療技術です。関節には滑液と呼ばれる液体が存在し、この液体は関節の潤滑や衝撃の吸収、栄養の供給を行っています。加齢や病気によって滑液の粘度が低下すると、関節の機能が低下し、痛みや運動制限が生じることがあります。この状態に対して、関節内にヒアルロン酸などの成分を注入することによって、滑液の性質を改善し、症状を緩和するのが関節内補充治療です。 この治療法には主にいくつかの種類があります。一つは、ヒアルロン酸製剤です。ヒアルロン酸は自然に体内に存在する成分で、関節の滑液の主成分でもあります。市販されているヒアルロン酸製剤は、分子の大きさや重合度が異なるさまざまなタイプがあり、適切な選択を行うことで効果を最大限に引き出せます。これにより、関節の滑らかさの向上や痛みの軽減が期待できます。 もう一つの種類として、コンドロイチン硫酸を含む製剤があります。コンドロイチン硫酸もまた関節の成分として重要で、ヒアルロン酸と組み合わせて使用されることが多いです。これらの成分は、関節の耐久性を高めたり、炎症を抑えたりする働きがあります。 さらに、最近では幹細胞療法や血小板豊富血漿（PRP）を用いた治療法も試みられています。幹細胞療法は、自己の細胞を使用して関節の修復を図るものです。PRPは、自身の血液から抽出した成分を関節に注入することで、組織の再生を促進します。これらの新しい技術は、従来のヒアルロン酸製剤やコンドロイチン硫酸製剤とは異なるメカニズムで治療を行うため、期待される効果が異なります。 関節内補充治療の用途は主に変形性関節症の治療ですが、その他にもリウマチ性関節炎やスポーツ障害、外傷後の関節痛などにも利用されています。特に膝関節に対する治療が一般的ですが、肩関節や股関節、足関節など様々な部位に適応されることがあります。この治療法は、患者にとって比較的負担が少ないことが特徴で、入院を必要とせず、通常は外来で行うことができます。 関節内補充治療の関連技術としては、診断技術や画像診断が挙げられます。例えば、MRIや超音波を用いることで関節の状態を詳しく評価し、最適な治療法を選定する手助けとなります。また、関節内補充治療を行う際には、正確な注入位置を確保するために、フルオロスコピーや超音波ガイドを利用することが一般的です。このような技術の進歩によって、関節内補充治療の精度や安全性が向上しています。 治療の効果は個人差がありますが、一般的には数回の治療を行うことで痛みの軽減や機能の改善が期待できるとされています。ただし、すべての患者に対して効果があるわけではなく、効果が見られない場合や副作用として一時的な腫れや痛みが生じることもあります。したがって、治療を受ける際には、医師と十分に相談し、自身の状態や治療の目的について理解を深めることが大切です。 今後も関節内補充治療は、より多くの患者にとって有用な治療法として広がっていくことが期待されます。新しい技術や製剤の開発が進めば、効果や対象疾患の範囲がさらに広がり、より良い治療結果が得られる可能性があります。そのため、研究の進展や技術革新に注目し続けることが重要です。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
